Affiliate Based Outsourcing for Regulatory Affairs

Practical tips on Affiliate Based Outsourcing including for Regulatory Affairsoptimization of local RA setup, management and relevant costs.

Webinar: Affiliate Based Outsourcing for Regulatory Affairs

Affiliate based Outsourcing Model for Regulatory Affairs works as a replacement or an extension of the company’s internal and local RA resources. Many challenges come up from managing your RA activities as sometimes their processes are not harmonized across different countries, the resources are not cost-optimized or simply there isn’t enough of them.

Thus, the purpose of this webinar is to share practical tips and insights on the effective optimization of local regulatory affairs setup, management and relevant costs.

You will learn about:

  • Advantages of ABO model with regards to Governance, Workload, Quality and Cost optimization.
  • Practical Tips for project setup, management, oversight and methodology.
  • Collaboration map between client and provider.

 

Expanding Your Geographical Reach?

Make use of our experience to expand across Europe. Explore your options in an informal chat with one of our experts.

Who Should Attend?

  • Global and regional RA Managers
  • Regulatory Strategy Managers
  • RA Partnerships Operations Manager
  • QA Managers supporting RA
  • RA Healthcare Compliance Managers

Duration: 40 min.

Speakers:

  • Head of Global Regulatory Affairs, Olga Bernardova;
  • Head of Project Managers for Regulatory Affairs, Claudia Ghislieri.
Olga Bernardova, MSc

Olga Bernardova, MSc

Head of Global Regulatory Affairs

Other content that might interest you:

Webinar: Effective IMPD Writing. The Quality Part

Webinar: Effective IMPD Writing. The Quality Part

Effective IMPD writing, including the quality part is a vital document that contains information about an investigational medicinal product and it is an essential part of the Clinical Trial Application (CTA), which is required by competent authorities in EU. The...

read more
Pharmacovigilance in the MENA Region

Pharmacovigilance in the MENA Region

This blog focuses on pharmacovigilance (PV) in the MENA Region; the Middle East and North Africa. We do this by comparing the MENA region and Europe and inter-country differences in the MENA region. Local legislation and requirements will be discussed, such as...

Selecting a Pharmacovigilance Drug Safety Database

Selecting a Pharmacovigilance Drug Safety Database

Selecting a Pharmacovigilance Drug Safety Database The WHO defines pharmacovigilance (PV) as the science and activities related to detecting, assessing, understanding, and preventing adverse effects of a medicinal product or any other possible drug-related problems. A...

How does the conflict between UA & RU impact the pharma industry?

How does the conflict between UA & RU impact the pharma industry?

Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability to continue operations. And with good reason. Russia's invasion of Ukraine affects millions of people, not just in this Eastern European nation but...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information